Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
|
Int J Pharm
|
2011
|
1.38
|
2
|
Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes.
|
Drug Metab Pharmacokinet
|
2012
|
0.87
|
3
|
Structure-activity relationships of receptor binding of 1,4-dihydropyridine derivatives.
|
Biol Pharm Bull
|
2008
|
0.86
|
4
|
Isolation and pharmacological characterization of fatty acids from saw palmetto extract.
|
Anal Sci
|
2009
|
0.85
|
5
|
Liposomal formulations of glucagon-like peptide-1: improved bioavailability and anti-diabetic effect.
|
Int J Pharm
|
2009
|
0.84
|
6
|
Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.
|
Int J Pharm
|
2008
|
0.82
|
7
|
Development of rapid and simultaneous quantitative method for green tea catechins on the bioanalytical study using UPLC/ESI-MS.
|
Biomed Chromatogr
|
2012
|
0.82
|
8
|
Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability.
|
Eur J Pharm Sci
|
2009
|
0.81
|
9
|
In vitro and in vivo characterization of new formulations of St. John's Wort extract with improved pharmacokinetics and anti-nociceptive effect.
|
Drug Metab Pharmacokinet
|
2011
|
0.81
|
10
|
Photoreactivity of amino acids: tryptophan-induced photochemical events via reactive oxygen species generation.
|
Anal Sci
|
2007
|
0.79
|
11
|
Photosafety assessments on pirfenidone: photochemical, photobiological, and pharmacokinetic characterization.
|
J Photochem Photobiol B
|
2013
|
0.79
|
12
|
Novel dry powder formulation of ovalbumin for development of COPD-like animal model: Physicochemical characterization and biomarker profiling in rats.
|
Eur J Pharm Sci
|
2009
|
0.79
|
13
|
Development of micellar reactive oxygen species assay for photosafety evaluation of poorly water-soluble chemicals.
|
Toxicol In Vitro
|
2013
|
0.79
|
14
|
Physicochemical and pharmacological characterization of alpha-tocopherol-loaded nano-emulsion system.
|
Int J Pharm
|
2010
|
0.79
|
15
|
Erythritol-based dry powder of glucagon for pulmonary administration.
|
Int J Pharm
|
2005
|
0.78
|
16
|
Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: anti-inflammatory effect in experimental asthmatic rats.
|
Peptides
|
2009
|
0.78
|
17
|
Combined use of in vitro phototoxic assessments and cassette dosing pharmacokinetic study for phototoxicity characterization of fluoroquinolones.
|
AAPS J
|
2011
|
0.78
|
18
|
Green tea extract affects the cytochrome P450 3A activity and pharmacokinetics of simvastatin in rats.
|
Drug Metab Pharmacokinet
|
2013
|
0.78
|
19
|
High-throughput screening strategy for photogenotoxic potential of pharmaceutical substances using fluorescent intercalating dye.
|
J Pharm Biomed Anal
|
2010
|
0.78
|
20
|
Crystalline form information from multiwell plate salt screening by use of Raman microscopy.
|
Pharm Res
|
2006
|
0.78
|
21
|
Pituitary adenylate cyclase-activating polypeptide (PACAP)-like immunoreactivity in the brain of a teleost, Uranoscopus japonicus: immunohistochemical relationship between PACAP and adenohypophysial hormones.
|
Regul Pept
|
2005
|
0.77
|
22
|
Comparative studies on physicochemical stability of cyclosporine A-loaded amorphous solid dispersions.
|
Int J Pharm
|
2012
|
0.77
|
23
|
Electrophoretic analysis of proteins and enantiomers using capillaries modified by a successive multiple ionic-polymer layer (SMIL) coating technique.
|
Anal Bioanal Chem
|
2006
|
0.77
|
24
|
Novel vasoactive intestinal peptide derivatives with improved stability protect rat alveolar L2 cells from cigarette smoke-induced cytotoxicity and apoptosis.
|
Peptides
|
2010
|
0.77
|
25
|
Overview of green tea interaction with cardiovascular drugs.
|
Curr Pharm Des
|
2015
|
0.77
|
26
|
In vitro/in vivo phototoxic risk assessments of griseofulvin based on photobiochemical and pharmacokinetic behaviors.
|
Eur J Pharm Sci
|
2009
|
0.77
|
27
|
Muscarinic Receptor Binding in Rat Bladder Urothelium and Detrusor Muscle by Intravesical Solifenacin.
|
Biol Pharm Bull
|
2016
|
0.77
|
28
|
Development of dry powder inhalation system of novel vasoactive intestinal peptide (VIP) analogue for pulmonary administration.
|
Life Sci
|
2006
|
0.76
|
29
|
Pharmacological effects and lung-binding characteristics of a novel VIP analogue, [R15, 20, 21, L17]-VIP-GRR (IK312532).
|
Regul Pept
|
2004
|
0.76
|
30
|
Respirable dry powder formulation of bleomycin for developing a pulmonary fibrosis animal model.
|
J Pharm Sci
|
2012
|
0.76
|
31
|
Development of meloxicam salts with improved dissolution and pharmacokinetic behaviors in rats with impaired gastric motility.
|
Pharm Res
|
2012
|
0.76
|
32
|
Pharmacological effects of saw palmetto extract in the lower urinary tract.
|
Acta Pharmacol Sin
|
2009
|
0.75
|
33
|
New dipyridamole salt with improved dissolution and oral bioavailability under hypochlorhydric conditions.
|
Drug Metab Pharmacokinet
|
2013
|
0.75
|
34
|
Pirfenidone in respirable powder form for the treatment of pulmonary fibrosis: a safer alternative to the current oral delivery system?
|
Ther Deliv
|
2013
|
0.75
|
35
|
In vitro photobiochemical characterization of sulfobutylether-β-cyclodextrin formulation of bufexamac.
|
J Pharm Biomed Anal
|
2011
|
0.75
|
36
|
Novel formulations of dipyridamole with microenvironmental pH-modifiers for improved dissolution and bioavailability under hypochlorhydria.
|
Int J Pharm
|
2012
|
0.75
|
37
|
Solid form selection of zwitterionic 5-HT4 receptor agonist.
|
Int J Pharm
|
2007
|
0.75
|
38
|
Evaluation of hydrate formation of a pharmaceutical solid by using diffuse reflectance infrared Fourier-transform spectroscopy.
|
J Pharm Biomed Anal
|
2007
|
0.75
|
39
|
Up-regulation of nicotinic and muscarinic receptor mRNA in rat bladder by repeated administration of nicotine in relation to the pharmacokinetics.
|
Life Sci
|
2011
|
0.75
|
40
|
Exploratory and regulatory assessments on photosafety of new drug entities.
|
Curr Drug Saf
|
2012
|
0.75
|
41
|
Fundamental studies on electrokinetic chromatography with PEGylated phospholipid micelles.
|
Anal Sci
|
2008
|
0.75
|
42
|
Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility.
|
Expert Opin Drug Deliv
|
2014
|
0.75
|
43
|
A newly developed enzyme-immunoassay for measuring the tissue contents of PACAP in fish.
|
Peptides
|
2002
|
0.75
|
44
|
Stable dry powder inhaler formulation of tranilast attenuated antigen-evoked airway inflammation in rats.
|
Eur J Pharm Biopharm
|
2010
|
0.75
|
45
|
Regional concentration and chromatographic characterization of pituitary adenylate cyclase-activating polypeptide (PACAP) in the brain of the bullfrog, Rana catesbeiana.
|
Zoolog Sci
|
2003
|
0.75
|
46
|
Physicochemical stability study on cyclosporine A loaded dry-emulsion formulation with enhanced solubility.
|
Chem Pharm Bull (Tokyo)
|
2015
|
0.75
|
47
|
Development of cyclosporine A-loaded dry-emulsion formulation using highly purified glycerol monooleate for safe inhalation therapy.
|
Int J Pharm
|
2013
|
0.75
|
48
|
Effect of spectroscopic properties on photostability of tamoxifen citrate polymorphs.
|
Int J Pharm
|
2006
|
0.75
|